Patents by Inventor Ilya Shamovsky

Ilya Shamovsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of heat shock RNA
    Patent number: 8889850
    Abstract: The present invention is directed to molecules that inhibit expression or a function of a eukaryotic Heat Shock RNA (HSR1) and their use for inhibiting a stress response or stress tolerance in a cell.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: November 18, 2014
    Assignee: New York University
    Inventors: Evgeny A. Nudler, Ilya Shamovsky
  • HEAT SHOCK RNA FROM VARIOUS SPECIES AND ITS USE IN ACTIVATION OF HEAT SHOCK TRANSCRIPTION FACTOR, IN TREATMENT OF VARIOUS DISEASES IN ANIMALS AND IN GENERATION OF STRESS-RESISTANT PLANTS
    Publication number: 20120142100
    Abstract: The present invention provides a novel RNA, designated herein as the “HSR1” (Heat Shock RNA), and its use together with translation elongation factor eEF1A in activation of heat shock transcription factor HSF. The invention further provides the use of HSR1 for generation of novel therapeutics for the treatment of various diseases in animals and for generation of stress-resistant plants.
    Type: Application
    Filed: October 13, 2011
    Publication date: June 7, 2012
    Applicant: NEW YORK UNIVERSITY
    Inventors: Evgeny A. Nudler, Ilya Shamovsky
  • Constitutively active fragments of eukaryotic heat shock RNA
    Patent number: 8067558
    Abstract: The present invention provides a novel RNA, designated herein as the “HSR1” (Heat Shock RNA), constitutively active HSR1 fragments, and the use of HSR1 and constitutively active HSR1 fragments for generation of novel therapeutics for the treatment of various diseases in animals and for generation of stress-resistant plants.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: November 29, 2011
    Assignee: New York University
    Inventors: Evgeny A. Nudler, Ilya Shamovsky
  • Heat shock RNA
    Patent number: 7919603
    Abstract: The present invention provides a novel RNA, designated herein as the “HSR1” (Heat Shock RNA), and its use together with translation elongation factor eEF1A in activation of heat shock transcription factor HSF. The invention further provides the use of HSR1 for generation of novel therapeutics for the treatment of cancer, inflammation, ischemia, neurodegeneration, age-related diseases, HIV infection, deafness, and related disorders.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: April 5, 2011
    Assignee: New York University
    Inventors: Evgeny A. Nudler, Ilya Shamovsky
  • HEAT SHOCK RNA FROM VARIOUS SPECIES AND ITS USE IN ACTIVATION OF HEAT SHOCK TRANSCRIPTION FACTOR, IN TREATMENT OF VARIOUS DISEASES IN ANIMALS AND IN GENERATION OF STRESS-RESISTANT PLANTS
    Publication number: 20090188009
    Abstract: The present invention provides a novel RNA, designated herein as the “HSR1” (Heat Shock RNA), and its use together with translation elongation factor eEF1A in activation of heat shock transcription factor HSF. The invention further provides the use of HSR1 for generation of novel therapeutics for the treatment of various diseases in animals and for generation of stress-resistant plants.
    Type: Application
    Filed: October 31, 2008
    Publication date: July 23, 2009
    Applicant: New York University
    Inventors: Evgeny A. Nudler, Ilya Shamovsky
  • HEAT SHOCK RNA AND ITS USE IN ACTIVATION OF HEAT SHOCK TRANSCRIPTION FACTOR AND TREATMENT OF CANCER, INFLAMMATION, ISCHEMIA, NEURODEGENERATION, AGE-RELATED DISEASES, HIV INFECTION, DEAFNESS, AND RELATED DISORDERS
    Publication number: 20070238682
    Abstract: The present invention provides a novel RNA, designated herein as the “HSR1” (Heat Shock RNA), and its use together with translation elongation factor eEF1A in activation of heat shock transcription factor HSF. The invention further provides the use of HSR1 for generation of novel therapeutics for the treatment of cancer, inflammation, ischemia, neurodegeneration, age-related diseases, HIV infection, deafness, and related disorders.
    Type: Application
    Filed: December 18, 2006
    Publication date: October 11, 2007
    Applicant: New York University
    Inventors: Evgeny Nudler, Ilya Shamovsky